Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
NCT05481177
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
250
Enrollment
FED
Sponsor class
Conditions
Long Haul COVID
Postural Orthostatic Tachycardia Syndrome
Interventions
DRUG:
Ivabradine
Sponsor
Uniformed Services University of the Health Sciences